Tritonix.ai

News / Taiwan / economic_daily

Taiho Oncology's Anti-Thrombotic Film Enters FDA Review, Targeting 2026 Launch

Health Technology · Pharmaceuticals: Major · economic_daily · 2026-09-06

6467

Taiho Oncology's BEQIA anti-thrombotic film has entered standard FDA review, with a target completion date of April 22 next year.

What Happened

FDA Review Status: Taiho Oncology announced that its New Drug Application (NDA) for the anti-thrombotic film BEQIA (TAH3311) has been accepted by the FDA. The drug has officially entered the standard review process, with a PDUFA target date set for April 22 of next year.

Technology and Application: Developed using Taiho's proprietary TDS transdermal/transmucosal delivery platform, BEQIA is an Apixaban-based film. It is designed to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation.

Market Potential: The reference drug, Eliquis, is a global leader in the small-molecule drug market, with 2025 U.S. sales reaching approximately $29.2 billion. Given the rising demand for anticoagulant therapies, the market outlook for this product remains highly favorable.

Strategic Milestone: The transition to the FDA review phase represents a significant step forward for Taiho in the U.S. market. A successful launch would solidify the company's position in the global anticoagulation treatment sector.

Read original

More in Health Technology

MedPlexus' L608 Inhaled Drug Receives FDA Phase 2 Approval for Scleroderma Treatment

Health Technology · economic_daily · 2026-09-20

MedPlexus has secured FDA approval for its Phase 2 clinical trial of L608, an inhaled drug candidate targeting systemic sclerosis-related digital ulcers.

6875

MediGrace Reaches Settlement with Terumo, Boosting Q3 Earnings

Health Technology · economic_daily · 2026-09-20

MediGrace has finalized a settlement agreement with Terumo Medical Corporation, securing $6 million in payments to be recognized in the third quarter.

6499

Al-Biomed to List on Go Incubation Board for Startup Firms on Sept 23

Health Technology · economic_daily · 2026-09-20

Biotech firm Al-Biomed will join the Go Incubation Board on September 23, focusing on innovative drug delivery platforms for Alzheimer's and eye diseases.

7437

Latest in Taiwan

September 21 Financial Briefing: TSMC Revenue Outlook, Trump's AI Force, and Record Bank Lending

Electronic Technology · economic_daily · 2026-09-20

Key financial highlights include TSMC's strong revenue forecast, Trump's plan for an 'AI Force,' record-breaking foreign currency lending by Taiwanese banks, and Intel's new partnership with AUO.

Fed Rate Hike Uncertainty Fades: Analysts Eye Potential Rebound in Taiwan Stocks

Electronic Technology · economic_daily · 2026-09-20

With the Fed's interest rate decision finalized, market uncertainty is clearing, positioning stocks like Chinatrust Financial and Actron for a potential rebound.

TSMC Revenue Outlook Boosts Taiwan Stocks; Index Eyes 48K Post-Holiday

Electronic Technology · economic_daily · 2026-09-20

With Fed uncertainty fading, analysts expect TSMC's September revenue to hit NT$520 billion, fueling a potential post-holiday rally for the Taiwan stock market.

2330

Institutional Investors Shift Focus Back to AI Stocks Amid Market Volatility

Electronic Technology · economic_daily · 2026-09-20

Despite recent foreign selling, institutional investors are pivoting back to AI-related stocks, with significant buying interest in UMC, Delta Electronics, and other key tech players.

1314, 2303, 2308, 2330, 2382, 2408, 2412, 2449, 2454, 2603, 2891, 3105, 3443, 3661, 5274, 6147, 6182, 6257, 6446, 6770